Publicacións (27) Publicacións de MIGUEL ÁNGEL TEJADA GIRÁLDEZ

filter_list

2025

  1. Editorial: Advances in the pharmacotherapy of chronic pelvic pain conditions

    Frontiers in Pharmacology

2024

  1. P2X3 and P2X2/3 receptors inhibition produces a consistent analgesic efficacy: A systematic review and meta-analysis of preclinical studies

    European Journal of Pharmacology, Vol. 984

  2. Pharmacological differences in postoperative cutaneous sensitivity, pain at rest, and movement-induced pain in laparotomized mice

    Biomedicine and Pharmacotherapy, Vol. 180

  3. The role of neutrophils in pain: systematic review and meta-analysis of animal studies

    Pain

2023

  1. Rodent Animal Models of Endometriosis-Associated Pain: Unmet Needs and Resources Available for Improving Translational Research in Endometriosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  2. Sigma-1 receptor agonism exacerbates immune-driven nociception: Role of TRPV1 + nociceptors

    Biomedicine and Pharmacotherapy, Vol. 167

2022

  1. FIBCD1 is an endocytic GAG receptor associated with a novel neurodevelopmental disorder

    EMBO Molecular Medicine, Vol. 14, Núm. 9

  2. Histological Grade and Tumor Stage Are Correlated with Expression of Receptor Activator of Nuclear Factor Kappa b (Rank) in Epithelial Ovarian Cancers

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  3. Identification of Altered Evoked and Non-Evoked Responses in a Heterologous Mouse Model of Endometriosis-Associated Pain

    Biomedicines, Vol. 10, Núm. 2

  4. Phenotypic drug screen uncovers the metabolic GCH1/BH4 pathway as key regulator of EGFR/KRAS-mediated neuropathic pain and lung cancer

    Science Translational Medicine, Vol. 14, Núm. 660

2021

  1. Preclinical models of endometriosis and interstitial cystitis/bladder pain syndrome: An Innovative Medicines Initiative-PainCare initiative to improve their value for translational research in pelvic pain

    Pain, Vol. 162, Núm. 9, pp. 2349-2365

  2. Sigma-1 receptor: A drug target for the modulation of neuroimmune and neuroglial interactions during chronic pain

    Pharmacological Research, Vol. 163

  3. Tetrodotoxin, a potential drug for neuropathic and cancer pain relief?

    Toxins, Vol. 13, Núm. 7

2020

  1. The search for translational pain outcomes to refine analgesic development: Where did we come from and where are we going?

    Neuroscience and Biobehavioral Reviews, Vol. 113, pp. 238-261

  2. Urinary bladder sigma-1 receptors: A new target for cystitis treatment

    Pharmacological Research, Vol. 155

2019

  1. Modulation by sigma-1 receptor of morphine analgesia and tolerance: Nociceptive pain, tactile allodynia and grip strength deficits during joint inflammation

    Frontiers in Pharmacology, Vol. 10, Núm. FEB

2018

  1. Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors

    Neuropharmacology, Vol. 135, pp. 328-342

  2. Targeting immune-driven opioid analgesia by sigma-1 receptors: Opening the door to novel perspectives for the analgesic use of sigma-1 antagonists

    Pharmacological Research, Vol. 131, pp. 224-230

2017

  1. Effects of tetrodotoxin in mouse models of visceral pain

    Marine Drugs, Vol. 15, Núm. 6

  2. Grip strength in mice with joint inflammation: A rheumatology function test sensitive to pain and analgesia

    Neuropharmacology, Vol. 125, pp. 231-242